Citations

Institution: Mayo Clinic Clear

Showing 10 of 108094 citations.

Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies
Goldman, Jennifer G. , Leverenz, James B., Blanc‬, ‪Frederic, Halliday, Glenda M. , Kantarci, Kejal, Lewis, Simon J.G. , Medsger, Helen Bundy, O’Brien, John T. , Scholz, Sonja W. , Ikeda, Manabu , Kantarci, Kejal , Blanc, Frédéric , O'Brien, John Tiernan , Halliday, Glenda , Goldman, Jennifer G , Scholz, Sonja W , Lewis, Simon J G , Kantarci, Kejal , Boeve, Bradley F. , Galasko, Douglas , Taylor, John‐Paul , Galvin, James E. , Leverenz, James B. , Lemstra, Afina W. , Leroi, Iracema , Litvan, Irene , Aarsland, Dag , McKeith, Ian G. , Taylor, Angela E.

Alzheimer's & Dementia | July 20, 2025 | Volume: 21 | Issue: 7 | Pages: No page available

10.1002/alz.70470 | PMID 40684248 Get It

Abstract Dementia with Lewy bodies (DLB), a progressive neurodegenerative disease with heterogeneous clinical presentations, greatly impacts patients, caregivers, and society. Despite its frequency, diagnosing and treating DLB remains challenging. Advances in in vivo biomarker assays reflecting underlying pathology are improving disease identification, diagnostic accuracy, and therapeutic development for biologically targeted, disease‐modifying agents. Consequently, definitions of Alzheimer's disease and Parkinson's disease (PD) have shifted to focus on pathological changes occurring before clinical features, with proposed frameworks for detecting pathological amyloid and tau, neurodegeneration, and other markers (National Institute on Aging‐Alzheimer's Association) and alpha‐synucleinopathy and dopaminergic degeneration (Neuronal α‐synuclein Disease Integrated Staging System, SynNeurGe). The biological frameworks, particularly those related to alpha‐synuclein (α‐synuclein), have sparked debate about unifying DLB and PD under a single pathobiologic disease. This paper discusses the implications of these biological frameworks for the DLB community, addressing topics regarding multiple pathologies and neurochemical systems, clinical heterogeneity, and functional impairment, and exploring the potential impact on clinical trials and care. Highlights DLB is a progressive neurodegenerative disease with varied clinical presentations. Diagnosing and treating DLB remains challenging despite its frequency. Biological frameworks are reshaping Alzheimer's and Parkinson's definitions. In vivo biomarkers are improving DLB identification and diagnostic accuracy. Debate exists regarding unifying DLB and Parkinson's under one pathobiology.
Real‐world epilepsy monitoring with ultra‐long‐term subcutaneous electroencephalography: A 15‐month prospective study
Viana, Pedro F. , Biondi, Andrea , Winston, Joel S. , Freestone, Dean R. , Brinkmann, Benjamin H. , Richardson, Mark P. , Duun-Henriksen, Jonas , Biondi, Andrea , Winston, Joel S , Freestone, Dean R , Schulze-Bonhage, Andreas , Brinkmann, Benjamin H , Richardson, Mark P , Viana, Pedro F , Duun‐Henriksen, Jonas , Schulze‐Bonhage, Andreas

Epilepsia | July 19, 2025 | Volume: 66 | Issue: 11 | Pages: 4476-4489

10.1111/epi.18566 | PMID 40682766 Get It

Abstract Objective Novel subcutaneous electroencephalography (sqEEG) systems enable prolonged, near‐continuous cerebral monitoring in real‐world conditions. Nevertheless, the feasibility, acceptability and overall clinical utility of these systems remain unclear. We report on the longest observational study using ultra‐long‐term sqEEG to date. Methods We conducted a 15‐month prospective, observational study including 10 adult people with treatment‐resistant epilepsy. After device implantation, patients were asked to record sqEEG, to use an electronic seizure diary, and to complete acceptability and usability questionnaires. sqEEG seizures were annotated visually, aided by automated detection. Individualized temporal patterns of seizure occurrence were assessed via circadian circular statistics and via Fano factor analysis. Results Over a median duration of 438 days, 10 patients recorded a median 18.8 h/day, totaling 71 984 h of real‐world sqEEG data. Adherence and acceptability remained high throughout the study. Although 754 sqEEG seizures were recorded across patients, more than half (52%) of these were not reported in the patient diary. Of the 140 (27%) diary reports not associated with an identifiable sqEEG seizure, the majority (68%) were reported as seizures with preserved awareness. The sqEEG to diary F1 agreement score was highly variable, ranging from .06 to .97. Patient‐specific patterns of circadian seizure occurrence and seizure clustering were found, including several relevant discrepancies between sqEEG and diary. Significance We demonstrate feasibility and high acceptability of ultra‐long‐term (months–years) sqEEG monitoring. These systems help provide real‐world, more objective seizure counting compared to patient diaries. It is possible to objectively monitor individual temporal fluctuations of seizure occurrence.
Beyond “other”: Exploring representation of minoritized individuals in headache research
Cheng, Nan , Singh, Rashmi B. Halker , Halker Singh, Rashmi B , Cheng, Nan

Headache: The Journal of Head and Face Pain | July 19, 2025 | Volume: 65 | Issue: 8 | Pages: 1460-1461

10.1111/head.15013 | PMID 40985132 Get It

Tactile Sensory Recovery in Neurotized Versus Non‐Neurotized Autologous Breast Reconstruction: A Systematic Review and Meta‐Analysis
Aristizábal, Alejandra , Herrera, Harrison, Escandón, Joseph M. , Ciudad, Pedro , Corral, Gabriel Del, Nazerali, Rahim , Mascaró, Andrés, Escandón, Joseph M , Delgado, Harrison Herrera

Microsurgery | July 19, 2025 | Volume: 45 | Issue: 5 | Pages: No page available

10.1002/micr.70096 | PMID 40682250 Get It

ABSTRACTBackgroundTactile sensory recovery in autologous breast reconstruction (ABR) has been shown to prevent injuries and improve quality of life. However, the studies comparing neurotized versus non‐neurotized outcomes are still controversial due to methodological heterogeneity. This review uses consistent and objective outcomes to evaluate the current evidence's qualitative characteristics and quantitative tactile sensory recovery.MethodsWe conducted a systematic electronic literature search from database inception through 10 February 2024, of the following databases: PubMed, Ovid MEDLINE, Embase, SCOPUS, and CINAHL to identify all studies reporting outcomes of tactile sensory recovery using the Semmes‐Weinstein Measuring scale in free‐flap ABR comparing neurotization versus non‐neurotization. The SWM scale score, demographic characteristics, and surgical features were extracted from each study. Due to the data heterogeneity within the studies, we transformed the data into means and pooled the qualitative information.ResultsWe identified 264 articles. After thorough screening, 12 fulfilled the inclusion criteria and were included in the qualitative synthesis. Finally, 7 were quantitatively analyzed with a total of 251 breasts that underwent ABR with free flap neurotization and 244 breasts without neurotization. This revealed a mean SWM score difference of −0.67 and a significant p‐value < 0.05. A subgroup DIEP flap analysis performed for 177 neurotized compared to 175 non‐eurotized flaps yielded a significant mean difference of −0.86 p < 0.05. There were no significant differences between groups in age (48.8 vs. 49.8, p = 0.5), history of chemotherapy (72 vs. 74, p = 0.91), radiotherapy (61 vs. 56, p = 0.84), or follow‐up time (21.85 vs. 25.09 months, p = < 0.05) that could have influenced tactile sensory recovery.ConclusionNeurotization in free‐flap ABR could allow better tactile sensory recovery than the spontaneous sensation gained without it. The additional surgical time required for coaptation is short, and no studies have reported associated complications, making it a safe procedure that can potentially improve patients´ quality of life. Nonetheless, higher‐quality studies, such as randomized control trials with standardized sensation testing and more rigorous methodologies, are needed before making final clinical recommendations.
Early Findings from the Multicenter RAPID Consortium on Papillary Craniopharyngiomas
Catalino, Michael P. , Pham, D. T. , Couldwell, William T. , Evans, James J., Callopy, Calen, Pacione, Donato , Suryadevara, Carter M. , Silverstein, Julie , Gardner, Paul A. , Barkhoudarian, Garni , Miranda, Juan Carlos Fernández, Benjamin, Carolina , Kshettry, Varun R. , Zada, Gabriel , Zwagerman, Nathan T. , Cheok, Stephanie , Wu, Kyle C., Little, Andrew S. , Karsy, Michael , Couldwell, William T , Chicoine, Michael , Kshettry, Varun R , Van Gompel, Jamie J , Palit, Sandhya R. , Karsy, Michael , Pham, Duy, Rennert, Robert C , Kim, Won Bae , Kim, Albert , Gompel, Jamie J. Van , Prevedello, Daniel M. , Mamelak, Adam N. , Pacult, Mark A.

Journal of Neurological Surgery Part B: Skull Base | July 18, 2025 | Volume: 87 | Issue: 04 | Pages: 406-413

10.1055/a-2646-2339 | PMID 42404182 Get It

Abstract Craniopharyngiomas are rare parasellar tumors, and papillary craniopharyngiomas (PCPs) represent 8 to 20% of cases. Interim analysis of retrospective data collected from the Registry of Adenomas of the Pituitary and Related Disorders (RAPID). Fourteen U.S.-based academic skull base centers between 2011 and 2023. Patients with PCPs. Demographic, imaging, surgical, and outcome variables. Ninety-nine patients with PCPs were included. The mean age was 51.8 ± 14.7, and 57.6% were male. Most tumors showed mixed cystic/solid components (67.5%), were transinfundibular (50.0%), and were treated with an endoscopic endonasal approach (74.5%), with 51.1% demonstrating gross total resection (GTR). Pituitary stalk was preserved in 51.9%. Permanent arginine vasopressin deficiency was seen in 67.1% and was associated with pituitary stalk sacrifice (p = 0.003). Cerebrospinal fluid leak was the most common nonendocrine postsurgical, 30-day complication (9.1%), reason for return to the operating room (3.1%), and reason for 90-day readmission (8.1%). Most patients (63.9%) received no adjuvant therapy; GTR was associated with decreased radiotherapy use (p = 0.0001). BRAFV600E mutation was detected in 64/69 tumors tested, although only one patient was treated with a BRAF inhibitor. A mean follow-up of 12.3 ± 14.6 months was seen for the group. RAPID consortium enabled the largest real-world clinical information dataset for PCPs. Early findings support that GTR and stalk preservation are important to outcomes. Iterative analysis and discussion of data led to the generation of a framework for future studies to fully leverage the capabilities of multicenter registries.
Vulvar Dermatofibrosarcoma Protuberans: Surgical Planning and Management Considerations for the Dermatologic Surgeon
Lachman, Nirusha , Salinas‐Alvarez, Yolanda , Demer, Addison M. , Vidal, Nahid Y. , Reinhart, Jacob P. , Salinas-Alvarez, Yolanda, Salinas-Alvarez, Yolanda

Dermatologic Surgery | July 18, 2025 | Volume: 52 | Issue: 1 | Pages: 24-30

10.1097/dss.0000000000004739 | PMID 40680296 Get It

Background Dermatofibrosarcoma protuberans (DFSP) arising in the vulvar and perivulvar region poses unique challenges to the dermatologic surgeon. The potential for broad subclinical extension and involvement of deeper and high-risk functional structures requires a strong knowledge of relevant anatomy. Careful considerations are required for preoperative arrangements, surgical day preparations, and postoperative surveillance to improve treatment outcomes and patient experiences. Objective The authors aim to provide a practical guide for the dermatologic surgeon, which outlines surgical planning and management recommendations for vulvar DFSP. Emphasis on pelvic anatomy through cadaveric and patient images as well as anatomical illustrations will be included. Materials and Methods A literature review was performed to identify evidence-based management recommendations for vulvar DFSP. Authors share anecdotal perioperative recommendations for optimizing the patient experience. A detailed pelvic dissection of a female cadaver was performed for anatomical depiction of relevant high-risk structures. Illustrations of sensory nerve distributions were created for reference. Conclusion Vulvar DFSP is a challenging cutaneous tumor in a sensitive anatomical location. As Mohs surgery offers clear advantages over wide local excision, the authors provide dermatologic surgeons with detailed anatomy review resources as well as recommendations and considerations for management and perioperative planning for this specialized site.
The Importance of Offering Genetic Counseling and Testing to All Persons Diagnosed With Frontotemporal Degeneration Spectrum Disorders
Dratch, Laynie , Jenny, Kim, Salmon, Kristiana , Crook, Ashley , Uhlmann, Wendy R. , Fong, Jamie , Klee, Victoria , MacLeod, Rhona, Chaouch, Amina , Lucente, Diane , Mantia, Sarah K., Pagano, Jennifer, Mu, Weiyi , Fong, Jamie , Goldman, Jill S , Chaouch, Amina , Goldman, Jill

Neurology | July 18, 2025 | Volume: 105 | Issue: 3 | Pages: No page available

10.1212/wnl.0000000000213814 | PMID 40680239 Get It

Ground-Glass Opacities in Pulmonary Arterial Hypertension—Results from the PVDOMICS Study
Menon, Divya Padmanabhan , Gochanour, Benjamin R. , Beck, Gerald J. , Erzurum, Serpil C. , Farha, Samar , Finet, J. Emanuel , Grünig, Gabriele , Hill, Nicholas S. , Lempel, Jason K. , Mathai, Stephen C. , Renapurkar, Rahul D., Hemnes, Anna , Mathai, Stephen C , Waxman, Aaron B. , DuBrock, Hilary M , Frantz, Robert P. , Rosenzweig, Erika B. , Borlaug, Barry A. , Hassoun, Paul M. , Hemnes, Anna R. , Horn, Evelyn M. , Leopold, Jane A. , Rischard, Franz , DuBrock, Hilary M.

Annals of the American Thoracic Society | July 18, 2025 | Volume: 22 | Issue: 12 | Pages: 1863-1873

10.1513/annalsats.202503-333oc | PMID 40680159 Get It

Abstract Rationale Pulmonary hypertension (PH) is associated with significant morbidity and mortality. Ground-glass opacities (GGOs) are common in Group 1 PH, but their clinical significance is unclear. Objectives We sought to characterize the clinical features and outcomes of patients with Group 1 PH with and without GGOs in the PVDOMICS study, a prospective multicenter cohort study aimed at deep phenotyping PH. Methods Patients with incident and prevalent PH were enrolled across seven U.S. centers. We included patients with Group 1 PH and excluded those with parenchymal lung disease or without chest imaging, resulting in a cohort of 242 patients. Results GGOs were common among patients with Group 1 PH (43% prevalence), associated with female sex, younger age, prostanoid use, and longer disease duration. GGOs were more common among patients with familial pulmonary arterial hypertension and pulmonary veno-occlusive disease. GGOs were associated with established markers of disease severity, including echocardiographic (right ventricular systolic pressure and tricuspid annular plane systolic excursion), biomarkers (N-terminal pro B-type natriuretic peptide), and worse hemodynamics (higher mean pulmonary artery pressure, pulmonary vascular resistance, and pulmonary artery wedge pressure). GGOs were associated with worse transplant-free survival (hazard ratio, 2.49; 95% confidence interval = 1.43–4.32; P = 0.001) and had independent prognostic value for predicting transplant-free survival after adjusting for European Society of Cardiology and European Respiratory Society risk stratification (hazard ratio, 2.19; 95% confidence interval = 1.20–3.99; P = 0.01). Conclusions Overall, GGOs were associated with specific clinical characteristics and disease phenotypes, as well as worse hemodynamics, longer disease duration, prostanoid use, and worse survival. Future studies evaluating the pathophysiology and “omic” correlates of GGOs are warranted. Clinical trial registered with www.clinicaltrials.gov (NCT02980887).
Perception of 30-Day Postoperative Function Compared with Quantified Performance: Factors Affecting Perceived Functional Decline in Patients Aged 80 Years and Older
Ma, Meixi , Remer, Sarah , Rosenthal, Ronnie A., Ko, Clifford Y. , Russell, Marcia M. , Zhang, Lindsey M, Peters, Xane D. , Zhang, Lindsey M. , Robinson, Thomas Nichols

Journal of the American College of Surgeons | July 18, 2025 | Volume: 241 | Issue: 6 | Pages: 1069-1083

10.1097/xcs.0000000000001496 | PMID 40680065 Get It

BACKGROUND: Older adults value the maintenance of function as an outcome of surgery, which can be evaluated by subjective perception and objective performance. The aims of this study were to explore whether these perceptions correlate with a decline in function, as measured by decreased ability to perform activities of daily living (ADLs), and to identify risk factors associated with worsened 30-day postoperative perceived physical function (PPF) in patients aged 80 years and older. STUDY DESIGN: American College of Surgeons NSQIP Geriatric Surgery Verification Pilot Program data (2015 to 2017) were used for patients aged 80 years and older. Chi-square tests were used to examine the concordance between 30-day outcomes of PPF and the quantified performance of ADLs. Multivariable logistic regression models identified risks associated with worsened PPF 30 days postoperatively. RESULTS: A total of 5,464 patients from 16 hospitals were included. The mean age was 85.7 years and 63% of participants were women. At 30 days postoperatively, 33% reported functional decline, whereas 28% had worsened quantified ADL performance (K = 0.25). Twenty-one percent of patients without quantified decline reported worsened PPF. Risk factors for worsened PPF were found for patient (eg American Society of Anesthesiologists class IV and V (odds ratio [OR] 2.2, 95% CI 1.5 to 3.2)), procedure (eg orthopaedic [OR 1.7, 95% CI 1.2 to 2.4]), and older adult-specific characteristics (eg preoperative fall [OR 1.9, 95% CI 1.2 to 2.9]). CONCLUSIONS: At 30 days postsurgery, there was discordance between quantified ADL performance and PPF in patients aged 80 years and older. Although assessing ADLs is a common approach to detect functional decline and loss of independence, directly asking patients about their PPF can serve as an additional important method for identifying functional decline, ensuring that the evaluation remains patient centered.